Hodgkin Lymphoma: An Update

Abstract 

Hodgkin lymphoma (HL) is an uncommon neoplasm arising from B lymphocytes. It affects both men and women, young and old. A lot is yet to be learned about this disease even though it has been around for more than a century. HL is considered a curable disease. Recently, research has gained better understanding of its pathogenesis, which has opened ideas for development of new treatments. As of today, the standard treatment of HL is chemotherapy and involved-field radiation therapy. However, these treatments are sometimes not easily tolerated and can cause long-term side effects. The main goal of finding new treatments is to improve quality of life and to prevent long-term side effects. Health care providers can play an important role in caring for patients with HL through education, supportive care, and symptom management.

Keywords:  B symptoms , Hodgkin lymphoma , lymphocytes and histiocytes , novel-targeted therapy , Reed-Sternberg cells